Figure 2

Proportions of patients in each disease activity score category at baseline, week 16, and week 24 of courses 1 and 2. Four hundred one patients started rituximab treatment. Second and third courses were given in 224 and 104 patients, respectively. DAS28, disease activity score using 28 joint counts.